Literature DB >> 15486081

Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.

Masakazu Niimi1, Kyoko Niimi, Yukie Takano, Ann R Holmes, Frank J Fischer, Yoshimasa Uehara, Richard D Cannon.   

Abstract

OBJECTIVES: Information on the function of Candida albicans ATP-binding cassette (ABC) membrane transporter Cdr1p has come from studying the effect of gene inactivation in C. albicans and from heterologous Cdr1p expression in the yeast Saccharomyces cerevisiae. These approaches, however, give only an indirect indication of Cdr1p function in C. albicans itself. The objective of this study was to determine Cdr1p function in C. albicans by induced overexpression of Cdr1p in a C. albicans CDR1-deleted strain.
METHODS: The C. albicans CDR1 open reading frame was fused to the C. albicans HEX1 promoter and used to complement a CDR1-null mutant to create strain FL3. The effect of inducing the FL3 HEX1 promoter, by growth on medium containing N-acetylglucosamine (GlcNAc) as the carbon source, on CDR1 expression and drug susceptibility was determined.
RESULTS: C. albicans FL3 cells grown on medium containing GlcNAc overexpressed CDR1 mRNA and a 170 kDa plasma membrane protein that reacted with anti-Cdr1p antibodies. Overexpression of Cdr1p in C. albicans FL3 conferred resistance to structurally unrelated chemicals such as terbinafine, brefeldin A, cerulenin and nigericin as well as to azole antifungal agents, but not resistance to polyene antibiotics. FK506, ascomycin and ciclosporin A chemosensitized FL3 to fluconazole. FL3 cells grown on GlcNAc effluxed 5.3 times as much Cdr1p substrate rhodamine 6G, over a 10 min period, as FL3 cells grown on glucose, and this rhodamine 6G efflux was inhibited by including fluconazole in the assay.
CONCLUSION: This study provides the first direct demonstration of Cdr1p pump activity in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486081     DOI: 10.1093/jac/dkh456

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

2.  Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.

Authors:  Luiz R Basso; Charles E Gast; Igor Bruzual; Brian Wong
Journal:  J Antimicrob Chemother       Date:  2015-01-27       Impact factor: 5.790

3.  Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis.

Authors:  Versha Rai; Manisha Gaur; Sudhanshu Shukla; Suneet Shukla; Suresh V Ambudkar; Sneha Sudha Komath; Rajendra Prasad
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

4.  Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans.

Authors:  Davina Hiller; Dominique Sanglard; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 5.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

Review 6.  Pathogenesis of Candida albicans biofilm.

Authors:  Christina Tsui; Eric F Kong; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2016-06       Impact factor: 3.166

7.  A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.

Authors:  Patrick Vandeputte; Guy Tronchin; Gérald Larcher; Emilie Ernoult; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

8.  Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.

Authors:  Irena Ivnitski-Steele; Ann R Holmes; Erwin Lamping; Brian C Monk; Richard D Cannon; Larry A Sklar
Journal:  Anal Biochem       Date:  2009-07-03       Impact factor: 3.365

9.  The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.

Authors:  Nidhi Puri; Manisha Gaur; Monika Sharma; Suneet Shukla; Suresh V Ambudkar; Rajendra Prasad
Journal:  Biochim Biophys Acta       Date:  2009-04-21

10.  Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.

Authors:  Sarah Tsao; Fariba Rahkhoodaee; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.